ConductScience.org, home

Paper22360481

Leishmaniasis: prevention, parasite detection and treatment.

Kobets T and 2 others. Curr Med Chem, 2012. Cited by 91 papers, by iCite.

Cite this record

ConductScience Library. Leishmaniasis: prevention, parasite detection and treatment. Papers, record 22360481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22360481

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Leishmaniasis: prevention, parasite detection and treatment.
PubMed
Journal
Curr Med Chem
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
91
iCite
Relative citation ratio, by iCite
3.49
iCite
Revised in PubMed
2019-08-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kobets TT
2Grekov II
3Lipoldova MM

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiprotozoal AgentsMajor topic
LeishmaniaMajor topic
LeishmaniasisMajor topic
Protozoan VaccinesMajor topic
Animals
DNA, Protozoan
Enzyme-Linked Immunosorbent Assay
Humans
Microscopy
Skin Tests
Vaccines, DNA

Source PubMed

Download CSV of topics

Cited by48

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.

PMIDTitleJournalYearIn PapersSource
42860538Antileishmanial potential of polar fractions from Amaranthus blitoides S. Watson, Caucalis platycarpos L., and Cistanche flava (C.A.Mey.) Korsh.: evidence from in vitro and in vivo studies.Trop Med Health2026https://conductscience.org/library/papers/42860538PubMed
41164189Non-additive strong gene interactions cause striking differences in organ pathology and cytokine response in Leishmaniasis.Front Immunol2025https://conductscience.org/library/papers/41164189PubMed
40978352Identification of Tripeptide Inhibitors Targeting MAPK3 in Leishmania martiniquensis and Leishmania orientalis Using Molecular Modeling, Virtual Screening, Molecular Dynamics, and In Vitro Approach.ACS Omega2025https://conductscience.org/library/papers/40978352PubMed
40600021A Century of Epidemiological Advances in Cutaneous and Visceral Leishmaniasis in Algeria.J Parasitol Res2025https://conductscience.org/library/papers/40600021PubMed
40330482Improving reproducibility and translational potential of mouse models: lessons from studying leishmaniasis.Front Immunol2025https://conductscience.org/library/papers/40330482PubMed
39918617Evaluation of the Anti-Leishmanial Activity of the Hydroalcoholic Extract of Green Algae (Spirogyra): Investigation of Weight Indicators (Lesion Size and Organ Weights) in BALB/c Mice.Acta Parasitol2025https://conductscience.org/library/papers/39918617PubMed
39328317Diagnostic challenges in cutaneous leishmaniasis due to atypical Leishmania infantum: pathologists' insights from re-emergence zones.Front Med (Lausanne)2024https://conductscience.org/library/papers/39328317PubMed
38839916An integrated bioinformatic analysis of microarray datasets to identify biomarkers and miRNA-based regulatory networks in leishmaniasis.Sci Rep2024https://conductscience.org/library/papers/38839916PubMed
38003236In Silico Exploration of the Trypanothione Reductase (TryR) of L. mexicana.Int J Mol Sci2023https://conductscience.org/library/papers/38003236PubMed
37631028Synthesis of 1,2,3-Triazole-Containing Methoxylated Cinnamides and Their Antileishmanial Activity against the Leishmania braziliensis Species.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37631028PubMed
37600780Functionally distinct regions of the locus Leishmania major response 15 control IgE or IFNγ level in addition to skin lesions.Front Immunol2023https://conductscience.org/library/papers/37600780PubMed
37520195In vitro evaluation of herbal based Lesh Nat B cream against Leishmania tropica.J Parasit Dis2023https://conductscience.org/library/papers/37520195PubMed
37404482Evaluation of Renal Function Profile in Human Visceral Leishmaniasis (Kala-Azar) Patients: A Case of Western Tigray, Ethiopia.Res Rep Trop Med2023https://conductscience.org/library/papers/37404482PubMed
36559136Development of Ag-ZnO/AgO Nanocomposites Effectives for Leishmania braziliensis Treatment.Pharmaceutics2022https://conductscience.org/library/papers/36559136PubMed
36457781Cytotoxic screening and in vitro effect of sodium chlorite against Leishmania major promastigotes.J Parasit Dis2022https://conductscience.org/library/papers/36457781PubMed
35692473In vitro efficacy of polymer coated miltefosine drug against leishmania tropica.J Parasit Dis2022https://conductscience.org/library/papers/35692473PubMed
33776999Unraveling the Role of Immune Checkpoints in Leishmaniasis.Front Immunol2021https://conductscience.org/library/papers/33776999PubMed
33193363Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4+ T Effector and Regulatory T Cells in Cutaneous Leishmaniasis.Front Immunol2020https://conductscience.org/library/papers/33193363PubMed
32784933Nanoparticles Formulations of Artemisinin and Derivatives as Potential Therapeutics for the Treatment of Cancer, Leishmaniasis and Malaria.Pharmaceutics2020https://conductscience.org/library/papers/32784933PubMed
31991635Synthesis of Biologically Active Molecules through Multicomponent Reactions.Molecules2020https://conductscience.org/library/papers/31991635PubMed

See all 48 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22360481

GET https://conductscience.org/api/papers/v1/22360481/cited_by?page=2